Cargando…
Validation of the Arabic Version of the Edmonton Symptom Assessment System
Quality cancer care is a team effort. In addition, patients’ symptoms change over the course of treatment. As such, the Edmonton Symptom Assessment System (ESAS) is a simple tool designed to quickly monitor symptom change. Here, we present the results from a two-phase study aimed at validating the A...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9915286/ https://www.ncbi.nlm.nih.gov/pubmed/36767943 http://dx.doi.org/10.3390/ijerph20032571 |
_version_ | 1784885867687444480 |
---|---|
author | Shamieh, Omar Alarjeh, Ghadeer Qadire, Mohammad Al Amin, Zaid AlHawamdeh, Abdelrahman Al-Omari, Mohammad Mohtadi, Omar Illeyyan, Abdullah Ayaad, Omar Al-Ajarmeh, Sawsan Al-Tabba, Amal Ammar, Khawlah Al-Rimawi, Dalia Abu-Nasser, Mahmoud Abu Farsakh, Fadi Hui, David |
author_facet | Shamieh, Omar Alarjeh, Ghadeer Qadire, Mohammad Al Amin, Zaid AlHawamdeh, Abdelrahman Al-Omari, Mohammad Mohtadi, Omar Illeyyan, Abdullah Ayaad, Omar Al-Ajarmeh, Sawsan Al-Tabba, Amal Ammar, Khawlah Al-Rimawi, Dalia Abu-Nasser, Mahmoud Abu Farsakh, Fadi Hui, David |
author_sort | Shamieh, Omar |
collection | PubMed |
description | Quality cancer care is a team effort. In addition, patients’ symptoms change over the course of treatment. As such, the Edmonton Symptom Assessment System (ESAS) is a simple tool designed to quickly monitor symptom change. Here, we present the results from a two-phase study aimed at validating the Arabic version of the ESAS (ESAS-A). Phase one involved the creation of two versions of the ESAS with both reverse and forward translations by bilingual, native Arabic speakers as well as evaluation by an expert panel. The reconciled version was then administered to 20 patients as a pilot from which to create the final version, which was then used with 244 patients. Phase two for the ESAS—involved an ESAS-based validation of 244 adults aged 18 years and older who were diagnosed with advanced cancer; then, further validation was completed in conjunction with two other symptom survey tools, the EORTC-Pal 15 and the HADS. The ESAS-A items possessed good internal consistency with an average Cronbach’s alpha of 0.84, ranging from 0.82 to 0.85. Moreover, the results of ESAS-A showed good agreement with those of EORTC QLQ- 15 PAL (r = 0.36 to 0.69) and HADS (r = 0.60 and 0.57) regarding anxiety and depression. We found the ESAS-A to be responsive to symptom change and a median time to completion of 3.73 min. The results of our study demonstrate that the ESAS-A is a reliable, valid, and feasible tool for the purposes of monitoring symptom change over the course of cancer treatment. |
format | Online Article Text |
id | pubmed-9915286 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-99152862023-02-11 Validation of the Arabic Version of the Edmonton Symptom Assessment System Shamieh, Omar Alarjeh, Ghadeer Qadire, Mohammad Al Amin, Zaid AlHawamdeh, Abdelrahman Al-Omari, Mohammad Mohtadi, Omar Illeyyan, Abdullah Ayaad, Omar Al-Ajarmeh, Sawsan Al-Tabba, Amal Ammar, Khawlah Al-Rimawi, Dalia Abu-Nasser, Mahmoud Abu Farsakh, Fadi Hui, David Int J Environ Res Public Health Article Quality cancer care is a team effort. In addition, patients’ symptoms change over the course of treatment. As such, the Edmonton Symptom Assessment System (ESAS) is a simple tool designed to quickly monitor symptom change. Here, we present the results from a two-phase study aimed at validating the Arabic version of the ESAS (ESAS-A). Phase one involved the creation of two versions of the ESAS with both reverse and forward translations by bilingual, native Arabic speakers as well as evaluation by an expert panel. The reconciled version was then administered to 20 patients as a pilot from which to create the final version, which was then used with 244 patients. Phase two for the ESAS—involved an ESAS-based validation of 244 adults aged 18 years and older who were diagnosed with advanced cancer; then, further validation was completed in conjunction with two other symptom survey tools, the EORTC-Pal 15 and the HADS. The ESAS-A items possessed good internal consistency with an average Cronbach’s alpha of 0.84, ranging from 0.82 to 0.85. Moreover, the results of ESAS-A showed good agreement with those of EORTC QLQ- 15 PAL (r = 0.36 to 0.69) and HADS (r = 0.60 and 0.57) regarding anxiety and depression. We found the ESAS-A to be responsive to symptom change and a median time to completion of 3.73 min. The results of our study demonstrate that the ESAS-A is a reliable, valid, and feasible tool for the purposes of monitoring symptom change over the course of cancer treatment. MDPI 2023-01-31 /pmc/articles/PMC9915286/ /pubmed/36767943 http://dx.doi.org/10.3390/ijerph20032571 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Shamieh, Omar Alarjeh, Ghadeer Qadire, Mohammad Al Amin, Zaid AlHawamdeh, Abdelrahman Al-Omari, Mohammad Mohtadi, Omar Illeyyan, Abdullah Ayaad, Omar Al-Ajarmeh, Sawsan Al-Tabba, Amal Ammar, Khawlah Al-Rimawi, Dalia Abu-Nasser, Mahmoud Abu Farsakh, Fadi Hui, David Validation of the Arabic Version of the Edmonton Symptom Assessment System |
title | Validation of the Arabic Version of the Edmonton Symptom Assessment System |
title_full | Validation of the Arabic Version of the Edmonton Symptom Assessment System |
title_fullStr | Validation of the Arabic Version of the Edmonton Symptom Assessment System |
title_full_unstemmed | Validation of the Arabic Version of the Edmonton Symptom Assessment System |
title_short | Validation of the Arabic Version of the Edmonton Symptom Assessment System |
title_sort | validation of the arabic version of the edmonton symptom assessment system |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9915286/ https://www.ncbi.nlm.nih.gov/pubmed/36767943 http://dx.doi.org/10.3390/ijerph20032571 |
work_keys_str_mv | AT shamiehomar validationofthearabicversionoftheedmontonsymptomassessmentsystem AT alarjehghadeer validationofthearabicversionoftheedmontonsymptomassessmentsystem AT qadiremohammadal validationofthearabicversionoftheedmontonsymptomassessmentsystem AT aminzaid validationofthearabicversionoftheedmontonsymptomassessmentsystem AT alhawamdehabdelrahman validationofthearabicversionoftheedmontonsymptomassessmentsystem AT alomarimohammad validationofthearabicversionoftheedmontonsymptomassessmentsystem AT mohtadiomar validationofthearabicversionoftheedmontonsymptomassessmentsystem AT illeyyanabdullah validationofthearabicversionoftheedmontonsymptomassessmentsystem AT ayaadomar validationofthearabicversionoftheedmontonsymptomassessmentsystem AT alajarmehsawsan validationofthearabicversionoftheedmontonsymptomassessmentsystem AT altabbaamal validationofthearabicversionoftheedmontonsymptomassessmentsystem AT ammarkhawlah validationofthearabicversionoftheedmontonsymptomassessmentsystem AT alrimawidalia validationofthearabicversionoftheedmontonsymptomassessmentsystem AT abunassermahmoud validationofthearabicversionoftheedmontonsymptomassessmentsystem AT abufarsakhfadi validationofthearabicversionoftheedmontonsymptomassessmentsystem AT huidavid validationofthearabicversionoftheedmontonsymptomassessmentsystem |